Biotech Startups

Unified Information Devices (UID) develops RFID solutions—including implantable and external microchips, readers, home cage monitoring systems, and custom software—for identifying and tracking laboratory research animals and lab items. It serves biomedical researchers and laboratories, integrating with LIMS and other data management platforms to automate data collection.

1 investor

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology. The company (which merged with Ultivue) serves biopharma and research customers with instruments and reagents for spatial biology.

1 investor

Ultrasonic Medical Mapping develops ultrasound-based medical mapping technology aimed at detecting pancreatic cancer at an early stage. The company positions its approach as a lower-cost diagnostic method in the medical device and cancer detection space.

1 investor

Unicorn Capital Partners is a venture capital firm, founded in December 2019, that invests in biotechnology companies. Its leadership has backed portfolio companies of which nine of eleven listed on NASDAQ.

1 investor

Unima develops a fast, low-cost diagnostic test and real-time disease surveillance system that lets users diagnose diseases at the point of care without lab equipment, delivering results in about 15 minutes. It serves healthcare providers and public health needs in the medical diagnostics space.

1 investor

Unimedic Pharma is a Swedish specialty pharmaceutical company that registers, launches, markets, and sells medicines across therapeutic areas such as emergency care, pain, infectious diseases, gastroenterology, urology, ADHD, and addiction care. It develops its own drugs, acts as a market representative for foreign pharma companies without Nordic presence, and supplies licensed medicines to the Nordic and northern European markets.

1 investor

A clinical research organization (CRO) serving innovative drug and medical device trials, with services spanning data management, biostatistics, and independent medical imaging review (IRC) for oncology, autoimmune, and neurological disease trials. It operates across China with offices in Shanghai, Beijing, Nanjing, Wuhan, and Guangzhou, supporting global multi-center projects.

1 investor

Univ8 Genomics develops next-generation sequencing (NGS) assays that run on a single universal workflow to detect genetic alterations such as rearrangements, translocations, sequence variants and copy number changes across different cancer types. Its tests serve clinical and diagnostic laboratories performing cancer and hematologic malignancy testing.

1 investor

Universal DX develops blood-based tests for early cancer detection, with a focus on colorectal cancer screening. The company runs clinical studies through a network of hospitals and gastrointestinal clinical teams across the U.S. and Europe.

1 investor

Unixell Biotech develops advanced cell therapy platforms including reprogramming, stem cell differentiation, lineage tracing, and gene editing technologies to create neural cell therapeutics for clinical applications. The company's lead program is UX-DA001, a midbrain dopamine precursor cell therapy for Parkinson's disease, which has received clinical trial approval from Chinese and US regulatory authorities.

1 investor

Unleash Immuno Oncolytics is an immuno-oncology company developing armed, conditionally replicating oncolytic viruses that target both tumor cells and the tumor-associated stroma to trigger a systemic anti-cancer immune response. Its lead product uses virally produced cytokines to disrupt tumor architecture and treat cancers, including metastatic disease.

1 investor

Unobio is a biotech company running drug discovery programs that begin with patient data and validate candidates against patient biology at each stage, aiming to improve translation rates from preclinical work to clinical trials. Its approach targets the failure of programs that clear in vitro and animal models but fail in later-stage clinical phases.

1 investor

Institute of Organic Chemistry and Biochemistry (IOCB) is a research institution under the Czech Academy of Sciences conducting basic research at the intersection of chemistry, biology, and computational sciences, with a systematic infrastructure for translating scientific discoveries into commercial products and technologies.

1 investor

Uptake Medical is a medical device company developing Bronchoscopic Thermal Vapor Ablation, a non-surgical, non-implant therapy that applies heated water vapor to ablate diseased lung tissue. The technology targets patients with pulmonary disease such as severe emphysema and lung cancer to improve breathing and pulmonary function.

1 investor

Uquifa is a supplier of active pharmaceutical ingredients and related products for the human and animal health markets, emphasizing quality standards and regulatory compliance. The company organizes its business around what it calls its "3P's": People, Products, and Plants.

1 investor

Urania Therapeutics develops treatments for genetic diseases and cancers caused by nonsense mutations, targeting monogenic diseases in which a single gene defect impairs production of a functional protein. It focuses on rare diseases that collectively affect a large patient population but currently lack curative therapies.

1 investor

UroMems designs and commercializes active implantable medical devices for urology, using proprietary microelectromechanical systems technology. The company serves urology patients and focuses on unmet clinical needs that affect quality of life.

1 investor

US BIOLOGIC develops orally delivered vaccines for disease prevention, applying partner technologies to its oral-delivery platform for wildlife, companion animals, food animals, and humans. The company handles funding, regulatory support, manufacturing, and distribution to commercialize these preventative products.

1 investor

US WorldMeds is a privately held specialty pharmaceutical company that licenses, develops, and markets medicines for patients with rare and challenging conditions. Its products include an FDA-approved engineered T-cell therapy for solid tumors.

1 investor

USDTL provides forensic toxicology testing and drug and alcohol testing services. The company serves clients requiring laboratory analysis and test collection.

1 investor

The US Oncology Network provides practice management, clinical, business, and technology support to a network of independent oncology physicians across the United States, focused on value-based cancer care delivered locally. It serves community-based oncology practices, helping them manage operations while participating in models such as the Enhancing Oncology Model.

1 investor

V-Ensure is a pharmaceutical company providing contract research, API development, and cGMP contract manufacturing services. It offers formulation and API R&D, analytical services, and produces injectable, solid oral, and liquid oral products.

1 investor

Vactech develops preventive vaccines and diagnostic technologies for type 1 diabetes, celiac disease, and enterovirus-related conditions. The company combines academic research with clinical development, advancing a patented preventive vaccine for type 1 diabetes through clinical trials with projected commercial impact in the US and EU.

1 investor

Vafseo (vadadustat) is a once-daily oral prescription medicine that treats anemia caused by chronic kidney disease in adults who have been on dialysis for at least three months. It works by increasing erythropoietin to help the body produce more red blood cells, and is marketed by Akebia Therapeutics.

1 investor